Current Methods and Caveats to Risk Factor Assessment in Cutaneous Squamous Cell Carcinoma (cSCC): A Narrative Review Aaron S. FarbergAlison L. FitzgeraldSarah T. Arron Review Open access 07 January 2022 Pages: 267 - 284
Dapsone in Hidradenitis Suppurativa: A Systematic Review Aswatha RabindranathnambiBalasubramanian Jeevankumar Review Open access 08 January 2022 Pages: 285 - 293
Topical Ectoine Application in Children and Adults to Treat Inflammatory Diseases Associated with an Impaired Skin Barrier: A Systematic Review Marion KauthOlga V. Trusova Review Open access 17 January 2022 Pages: 295 - 313
Role of Interleukin 36 in Generalised Pustular Psoriasis and Beyond Kazumitsu Sugiura Review Open access 21 January 2022 Pages: 315 - 328
Photoprotection in Outdoor Sports: A Review of the Literature and Recommendations to Reduce Risk Among Athletes Yolanda GilaberteCarles TrullàsMagdalena de Troya-Martín Review Open access 29 January 2022 Pages: 329 - 343
Exposome and Skin: Part 1. Bibliometric Analysis and Review of the Impact of Exposome Approaches on Dermatology Manuel Molina-GarcíaCorinne GrangerSusana Puig Review Open access 03 February 2022 Pages: 345 - 359
Exposome and Skin. Part 2. The Influential Role of the Exposome, Beyond UVR, in Actinic Keratosis, Bowen’s Disease and Squamous Cell Carcinoma: A Proposal Manuel Molina-GarcíaJosep MalvehySusana Puig Review Open access 03 February 2022 Pages: 361 - 380
Unmet Educational Needs and Clinical Practice Gaps in the Management of Generalized Pustular Psoriasis: Global Perspectives from the Front Line Bruce StroberJoyce LemanYukari Okubo Original Research Open access 13 December 2021 Pages: 381 - 393
Assessment of Life Quality, Stress and Physical Activity Among Patients with Psoriasis Julia NowowiejskaAnna BaranIwona Flisiak Original Research Open access 16 December 2021 Pages: 395 - 406
Impact of Risankizumab on PASI90 and DLQI0/1 Duration in Moderate-to-Severe Psoriasis: A Post Hoc Analysis of Four Phase 3 Clinical Trials Mark G. LebwohlAhmed M. SolimanAndreas Pinter Original Research Open access 18 December 2021 Pages: 407 - 418
Development of a Predictive Model for Screening Patients with Psoriasis at Increased Risk of Psoriatic Arthritis Yiyi WangLingyan ZhangWei Li Original Research Open access 19 December 2021 Pages: 419 - 433
Methoxy-Monobenzoylmethane Protects Skin from UV-Induced Damages in a Randomized, Placebo Controlled, Double-Blinded Human In Vivo Study and Prevents Signs of Inflammation While Improving the Skin Barrier Michael TermerAnita JaegerJoerg von Hagen Original Research Open access 22 December 2021 Pages: 435 - 449
Apremilast Prolongs the Time to First Biologic Therapy in Japanese Patients with Psoriasis Masayuki TanakaYasushi OzekiTaichi Nakamura Original Research Open access 24 December 2021 Pages: 451 - 466
Intensity of Local Skin Reactions During 5-Fluorouracil Treatment Related to the Number of Actinic Keratosis Lesions: A Post Hoc, Exploratory Analysis Eggert StockflethNathalie BégeaultAlain Delarue Original Research Open access 26 December 2021 Pages: 467 - 479
Ixekizumab 80 mg Every 2 Weeks Treatment Beyond Week 12 for Japanese Patients with Generalized Pustular Psoriasis and Erythrodermic Psoriasis Akimichi MoritaYukari OkuboYoshinori Umezawa Original Research Open access 29 December 2021 Pages: 481 - 494
Deucravacitinib in Moderate to Severe Psoriasis: Clinical and Quality-of-Life Outcomes in a Phase 2 Trial Diamant ThaçiBruce StroberAlice B. Gottlieb Original Research Open access 13 January 2022 Pages: 495 - 510
Effectiveness and Safety of Secukinumab for Psoriasis in a Real-World Clinical Setting in the Asia-Pacific and Middle East Regions: Results from the REALIA Study Peter FoleyTsen-Fang TsaiYu-Huei Huang Original Research Open access 17 January 2022 Pages: 511 - 527
The Impact of Stress-Coping Strategies and the Severity of Psoriasis on Self-Esteem, Illness Acceptance and Life Satisfaction Beata KowalewskaElżbieta Krajewska-KułakMarek Sobolewski Original Research Open access 18 January 2022 Pages: 529 - 543
Validation of Patient Identification Algorithms for Atopic Dermatitis Using Healthcare Databases Gustaf OrtsäterAnna De GeerMaureen P. Neary Original Research Open access 18 January 2022 Pages: 545 - 559
Efficacy of Risankizumab versus Secukinumab in Patients with Moderate-to-Severe Psoriasis: Subgroup Analysis from the IMMerge Study Jeffrey J. CrowleyRichard G. LangleyRichard B. Warren Original Research Open access 20 January 2022 Pages: 561 - 575
Facial Acne: A Randomized, Double-Blind, Placebo-Controlled Study on the Clinical Efficacy of a Symbiotic Dietary Supplement Fabio RinaldiLaura MarottaDaniela Pinto Original Research Open access 21 January 2022 Pages: 577 - 589
Clinical Utility of the 40-Gene Expression Profile (40-GEP) Test for Improved Patient Management Decisions and Disease-Related Outcomes when Combined with Current Clinicopathological Risk Factors for Cutaneous Squamous Cell Carcinoma (cSCC): Case Series Jeremiah H. AuPerry B. HooperAlly-Khan Somani Case Series Open access 23 December 2021 Pages: 591 - 597
Lentigo Maligna on a Difficult Location of the Face Treated with 5% Imiquimod: A Case Report of 2-Year Follow-Up Magdalena Misiak-GalazkaJoanna CzuwaraLidia Rudnicka Case Report Open access 26 January 2022 Pages: 599 - 604
Adalimumab Biosimilar-Induced Severe Paradoxical Palmoplantar Pustulosis in a Patient with Psoriasis and Psoriatic Arthritis Successfully Treated with Ixekizumab Spyridon GkalpakiotisMarketa FridmanSimona Tivadar Case Report Open access 24 January 2022 Pages: 605 - 609